Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

727 public trials 122 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Recruiting

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

NCT05278208

Conditions
Anaplastic Ependymoma, Brain Diseases, Brain Neoplasms, +32 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

NCT06450041

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Comer Children's Hospital, University of Chicago Chicago, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

NCT05382338

Conditions
Childhood Medulloblastoma, Glioma, Medulloblastoma, +8 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 108 locations
View Trial Details
Recruiting

A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

NCT07698899

Conditions
CNS Metastases, Central Nervous System Metastasis, Glioma, +11 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Digoxin Medulloblastoma Study

NCT06701812

Conditions
Glioma, Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH, +8 more
Locations
  • University of Alabama at Birmingham Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Childrens Hospital Little Rock, Arkansas, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 15 locations
View Trial Details
Recruiting

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

NCT06541262

Conditions
Ewing Sarcoma, Liposarcoma, Myosarcoma, +19 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 22 locations
View Trial Details

Related conditions